Sandoz/Momenta’s Copaxone Generic Clears FDA, But Court Action May Guide Launch Timing

Commercialization of the generic, which carries the brand name Glatopa, prior to a Federal Circuit ruling seems highly unlikely because it would be “at risk” and in the face of other rulings favoring Teva.